Frequency and prognostic impact of

Adolescent Adult Aged Alleles Biomarkers Biomarkers, Tumor Child Child, Preschool DNA Mutational Analysis Female Follow-Up Studies Gene Frequency Genetic Variation Humans Infant Infant, Newborn Male Mastocytosis, Systemic / diagnosis Middle Aged Mutation Prognosis Proto-Oncogene Proteins c-kit / genetics Symptom Assessment Young Adult

Journal

Blood
ISSN: 1528-0020
Titre abrégé: Blood
Pays: United States
ID NLM: 7603509

Informations de publication

Date de publication:
01 08 2019
Historique:
received: 19 11 2018
accepted: 23 05 2019
pubmed: 4 6 2019
medline: 14 1 2020
entrez: 2 6 2019
Statut: ppublish

Résumé

Indolent systemic mastocytosis (ISM) patients have a normal life expectancy, except in the 5% to 10% of cases that progress to more advanced SM (advSM), which has a significantly poorer outcome. Mutations in genes other than

Identifiants

DOI: 10.1182/blood.2018886507 PMID: 31151985
pubmed: 31151985
pii: S0006-4971(20)42373-0
doi: 10.1182/blood.2018886507
doi:

Substances chimiques

Biomarkers 0
Biomarkers, Tumor 0
Proto-Oncogene Proteins c-kit EC 2.7.10.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

456-468

Informations de copyright

© 2019 by The American Society of Hematology.

Auteurs

Javier I Muñoz-González (JI)

Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytometry Service, NUCLEUS, Universidad de Salamanca, Salamanca, Spain.
Spanish Network on Mastocytosis, Toledo and Salamanca, Spain.
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain.
ORCID: 0000-0001-8982-5663

Iván Álvarez-Twose (I)

Spanish Network on Mastocytosis, Toledo and Salamanca, Spain.
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
Instituto de Estudios de Mastocitosis de Castilla La Mancha, Virgen del Valle Hospital, Toledo, Spain; and.
ORCID: 0000-0002-1190-4473

María Jara-Acevedo (M)

Spanish Network on Mastocytosis, Toledo and Salamanca, Spain.
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain.
Sequencing Service and.
ORCID: 0000-0001-7965-7512

Ana Henriques (A)

Spanish Network on Mastocytosis, Toledo and Salamanca, Spain.
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
Instituto de Estudios de Mastocitosis de Castilla La Mancha, Virgen del Valle Hospital, Toledo, Spain; and.

Esther Viñas (E)

Spanish Network on Mastocytosis, Toledo and Salamanca, Spain.
Sequencing Service and.

Carlos Prieto (C)

Bioinformatics Service, NUCLEUS, Universidad de Salamanca, Salamanca, Spain.
ORCID: 0000-0001-8178-9768

Laura Sánchez-Muñoz (L)

Spanish Network on Mastocytosis, Toledo and Salamanca, Spain.
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
Instituto de Estudios de Mastocitosis de Castilla La Mancha, Virgen del Valle Hospital, Toledo, Spain; and.

Carolina Caldas (C)

Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytometry Service, NUCLEUS, Universidad de Salamanca, Salamanca, Spain.
Spanish Network on Mastocytosis, Toledo and Salamanca, Spain.
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain.

Andrea Mayado (A)

Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytometry Service, NUCLEUS, Universidad de Salamanca, Salamanca, Spain.
Spanish Network on Mastocytosis, Toledo and Salamanca, Spain.
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain.
ORCID: 0000-0003-1498-7398

Almudena Matito (A)

Spanish Network on Mastocytosis, Toledo and Salamanca, Spain.
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
Instituto de Estudios de Mastocitosis de Castilla La Mancha, Virgen del Valle Hospital, Toledo, Spain; and.
ORCID: 0000-0002-9547-4844

Noelia Dasilva-Freire (N)

Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytometry Service, NUCLEUS, Universidad de Salamanca, Salamanca, Spain.
Spanish Network on Mastocytosis, Toledo and Salamanca, Spain.
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain.

Alberto Orfao (A)

Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytometry Service, NUCLEUS, Universidad de Salamanca, Salamanca, Spain.
Spanish Network on Mastocytosis, Toledo and Salamanca, Spain.
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain.
ORCID: 0000-0002-0007-7230

Andrés C García-Montero (AC)

Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytometry Service, NUCLEUS, Universidad de Salamanca, Salamanca, Spain.
Spanish Network on Mastocytosis, Toledo and Salamanca, Spain.
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain.
ORCID: 0000-0003-4360-1386

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adolescent › Frequency and prognostic impact of
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Frequency and prognostic impact of
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Frequency and prognostic impact of
questionsmedicales.fr › Phénomènes génétiques › Structures génétiques › Génome › Composants de génome › Gènes › Allèles › Frequency and prognostic impact of
questionsmedicales.fr › Facteurs biologiques › Marqueurs biologiques › Frequency and prognostic impact of
questionsmedicales.fr › Facteurs biologiques › Marqueurs biologiques › Marqueurs biologiques tumoraux › Frequency and prognostic impact of
questionsmedicales.fr › Personnes › Tranches d'âge › Enfant › Frequency and prognostic impact of
questionsmedicales.fr › Personnes › Tranches d'âge › Enfant › Enfant d'âge préscolaire › Frequency and prognostic impact of
questionsmedicales.fr › Techniques d'investigation › Techniques génétiques › Analyse de séquence › Analyse de séquence d'ADN › Analyse de mutations d'ADN › Frequency and prognostic impact of
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études de suivi › Frequency and prognostic impact of
questionsmedicales.fr › Phénomènes génétiques › Fréquence d'allèle › Frequency and prognostic impact of
questionsmedicales.fr › Phénomènes génétiques › Variation génétique › Frequency and prognostic impact of
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Frequency and prognostic impact of
questionsmedicales.fr › Personnes › Tranches d'âge › Nourrisson › Frequency and prognostic impact of
questionsmedicales.fr › Personnes › Tranches d'âge › Nourrisson › Nouveau-né › Frequency and prognostic impact of
questionsmedicales.fr › Maladies du système immunitaire › Troubles de l'activation mastocytaire › Mastocytose › Mastocytose généralisée › Frequency and prognostic impact of
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Frequency and prognostic impact of
questionsmedicales.fr › Phénomènes génétiques › Variation génétique › Mutation › Frequency and prognostic impact of
questionsmedicales.fr › Diagnostic › Pronostic › Frequency and prognostic impact of
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines tumorales › Protéines oncogènes › Protéines proto-oncogènes › Protéines proto-oncogènes c-kit › Frequency and prognostic impact of
questionsmedicales.fr › Diagnostic › Techniques et procédures diagnostiques › Évaluation des symptômes › Frequency and prognostic impact of
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Jeune adulte › Frequency and prognostic impact of